Avantax Advisory Services, Inc. Astrazeneca PLC Transaction History

Avantax Advisory Services, Inc.

$14.9 Billion
Q3 2024

A detailed history of Avantax Advisory Services, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 107,377 shares of AZN stock, worth $7.18 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

107,377

Previous 102,428 4.83%

Holding current value

$7.18 Million

Previous $7.99 Million 4.73%

% of portfolio

0.06%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $379,439 - $433,631	4,949 Added 4.83%	107,377 $8.37 Million
Q2 2024 Aug 09, 2024	BUY	$66.81 - $80.83 $4.76 Million - $5.76 Million	71,222 Added 228.23%	102,428 $7.99 Million
Q1 2024 May 08, 2024	BUY	$61.03 - $69.57 $256,142 - $291,985	4,197 Added 15.54%	31,206 $2.11 Million
Q4 2023 Feb 07, 2024	SELL	$61.89 - $69.28 $11,449 - $12,816	-185 Reduced 0.68%	27,009 $1.82 Million
Q3 2023 Nov 07, 2023	SELL	$64.85 - $71.7 $51,685 - $57,144	-797 Reduced 2.85%	27,194 $1.84 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $210,778 - $228,567	-3,015 Reduced 9.72%	27,991 $2 Million
Q1 2023 Apr 28, 2023	SELL	$63.15 - $71.6 $176,314 - $199,907	-2,792 Reduced 8.26%	31,006 $2.15 Million
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $159,323 - $207,023	2,939 Added 9.52%	33,798 $2.29 Million
Q3 2022 Nov 01, 2022	SELL	$53.02 - $135.75 $1,219 - $3,122	-23 Reduced 0.07%	30,859 $1.69 Million
Q2 2022 Aug 02, 2022	BUY	$59.26 - $71.14 $100,327 - $120,440	1,693 Added 5.8%	30,882 $2.04 Million
Q1 2022 Apr 27, 2022	SELL	$55.72 - $67.12 $128,713 - $155,047	-2,310 Reduced 7.33%	29,189 $1.94 Million
Q4 2021 Jan 24, 2022	BUY	$54.02 - $63.83 $15,341 - $18,127	284 Added 0.91%	31,499 $1.84 Million
Q3 2021 Oct 21, 2021	SELL	$55.56 - $60.79 $101,730 - $111,306	-1,831 Reduced 5.54%	31,215 $1.87 Million
Q2 2021 Jul 29, 2021	SELL	$48.42 - $60.18 $133,251 - $165,615	-2,752 Reduced 7.69%	33,046 $1.98 Million
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $6,272 - $7,240	133 Added 0.37%	35,798 $1.78 Million
Q4 2020 Jan 22, 2021	SELL	$48.52 - $58.02 $1.2 Million - $1.44 Million	-24,824 Reduced 41.04%	35,665 $1.78 Million
Q3 2020 Oct 14, 2020	BUY	$53.07 - $61.1 $936,314 - $1.08 Million	17,643 Added 41.18%	60,489 $3.31 Million
Q2 2020 Aug 06, 2020	BUY	$43.1 - $55.31 $6,206 - $7,964	144 Added 0.34%	42,846 $2.27 Million
Q1 2020 Apr 30, 2020	BUY	$37.79 - $51.33 $190,763 - $259,113	5,048 Added 13.41%	42,702 $1.91 Million
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $182,875 - $217,331	4,307 Added 12.92%	37,654 $1.88 Million
Q3 2019 Nov 08, 2019	BUY	$40.12 - $45.47 $148,123 - $167,875	3,692 Added 12.45%	33,347 $1.49 Million
Q2 2019 Aug 06, 2019	BUY	$37.28 - $41.68 $214,509 - $239,826	5,754 Added 24.07%	29,655 $1.22 Million
Q1 2019 May 13, 2019	BUY	$35.49 - $43.02 $79,000 - $95,762	2,226 Added 10.27%	23,901 $966,000
Q4 2018 Feb 13, 2019	BUY	$36.86 - $41.49 $798,940 - $899,295	21,675 New	21,675 $820,000

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $207B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.

Account

Avantax Advisory Services, Inc. Astrazeneca PLC Transaction History